SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016852
Filing Date
2023-10-26
Accepted
2023-10-26 16:05:23
Documents
14
Period of Report
2023-10-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20231026x8k.htm   iXBRL 8-K 41033
2 EX-99.1 tmb-20231026xex99d1.htm EX-99.1 19219
3 GRAPHIC tmb-20231026xex99d1001.jpg GRAPHIC 8335
  Complete submission text file 0001558370-23-016852.txt   194673

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20231026.xsd EX-101.SCH 3139
5 EX-101.LAB tmb-20231026_lab.xml EX-101.LAB 15268
6 EX-101.PRE tmb-20231026_pre.xml EX-101.PRE 9932
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231026x8k_htm.xml XML 4714
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 231350153
SIC: 2834 Pharmaceutical Preparations